Stock screenerAll disclosures →
EDGAR →
ROIV
Conviction 80HealthcareScan · Mon, Jul 20, 2026ROIV$34.06-1.32%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
6
7
Vol MA14 4.77M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price34.06
Change-1.32%
Gap+0.41%
Rel volume0.65×
Avg volume6M
Avg $ vol206.94M
SMA 2034.66
SMA 5031.57
SMA 20025.60
Price vs 50+7.87%
Price vs 200+33.04%
MA stackbullish
50/200 cross—
Supertrendup · 33.10
RSI (14)53
MACD hist-0.34
MACD crossbear · 4d
Stoch %K / %D14 / 17
ADX (14)36
+DI / −DI21 / 15
RSI divergence—
MACD divergenceBearish
ATR %+3.38%
ADR %3.44%
52w high36.81
52w low11.17
From 52w high-7.48%
Above 52w low+204.88%
New 52w highNo
SqueezeOff
Bollinger width14.69%
%B0.38
Donchian pos53.25%
Donchian high37.00
Donchian low30.70
AVWAP (52w high)34.85
vs AVWAP high-2.29%
AVWAP (52w low)23.07
vs AVWAP low+47.59%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d0.65×
Avg vol (14d)4.77M
Avg vol (20d)6M
Avg $ vol (20d)206.94M
Market cap24.49B
RS 3m (vs SPY)+12.29%
RS 6m (vs SPY)+37.27%
RS line new highNo
Trend template8/8
Technical rank86.1
1 week-1.32%
1 month+9.15%
3 months+14.16%
6 months+46.16%
1 year+192.32%
YTD+55.29%
P/E-81.71
P/B5.41
P/S—
P/FCF-32.29
EPS-0.5400
Div yield—
ROE-6.62%
ROA-5.25%
Debt/Eq0.05
Current18.37
EV/EBITDA-45.53
Gross margin—
Net margin—
Rev growth-71.57%
EPS growth-74.30%
Price target36.11
Target upside6.03%
Analyst ratingBuy
Institutional80.76%
Ent. value23.3B
Revenue2M
Net income-265.89M
Gross profit—
Free cash flow-758.56M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out719.27M
Employees721
ListedFri, Oct 1, 2021
Free float371.02M
Float %51.8%
Short interest33.21M
Days to cover4.3d
Short volume53.5%
Squeeze score48 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.46 vs −$0.38
Last surprise-21.1% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank86.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance36.45
Support28.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Wed, Dec 31, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in ROIV · 3 recent
Insider activity
SEC Form 4 transactions in ROIV · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Gold Daniel Allen Director · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-30 | Sell | 200K | $7.1M | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-30 | Sell | 12.38K | $437K | 2026-06-30 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
Gold Daniel Allen Director · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
Gold Daniel Allen Director · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
MANCHESTER KEITH S Director · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-29 | Sell | 200K | $6.9M | 2026-06-29 | 2026-06-30 |
QVT Financial LP Insider · Common Shares · 2026-06-29 | Sell | 600K | $21M | 2026-06-29 | 2026-06-30 |
SEC filings
EDGAR filings in ROIV · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.